BCL2L1 and neoplasm: These results implied that Bcl-xL-favored splicing may play a crucial role in tumor progression and radioresistance development of A172 cells, it also implied that the combination of X-ray radiotherapy and BCLX splicing modulation may effectively enhance the radiosensitivity of tumor cells (Fig. 6H).